Statistics for Development of an antisense oligonucleotide-mediated exon skipping therapeutic strategy for Mucolipidosis II: validation at RNA level
Total visits
| views | |
|---|---|
| Development of an antisense oligonucleotide-mediated exon skipping therapeutic strategy for Mucolipidosis II: validation at RNA level | 74 |
Total visits per month
| views | |
|---|---|
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 2 |
| November 2025 | 0 |
| December 2025 | 0 |
File Visits
| views | |
|---|---|
| Matos, 2020 (delTC -RNA).pdf | 1 |
Top country views
| views | |
|---|---|
| United States | 34 |
| Germany | 12 |
| Portugal | 11 |
| Israel | 6 |
| China | 4 |
| Canada | 2 |
| Unknown Region | 2 |
| France | 1 |
| United Kingdom | 1 |
| India | 1 |
Top city views
| views | |
|---|---|
| Canelas | 2 |